Area of expertise: Biochemistry (mode of action and resistance)

Anthony Maxwell
Group Leader
John Innes Centre
more

Stefan Miller
Scientific Advisor
Lysando
more

Francois Moreau
Chief Scientific Officer
Tamrisa Innovation
more

Rolf Müller
Managing Director
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
more

Alex O’Neill
Professor
University of Leeds
more

Malcolm Page
Formerly Roche, Switzerland
more

David Pompliano
Founding Chief Scientific Officer
Lodo Therapeutics
more

Katie Prosen
Senior Associate
Venatorx Pharmaceuticals
more

Hans-Georg Sahl
Emeritus Professor
University of Bonn
more

William Shafer
Professor of Microbiology and Immunology
Emory University School of Medicine
more